JP2023527352A5 - - Google Patents
Info
- Publication number
- JP2023527352A5 JP2023527352A5 JP2022572524A JP2022572524A JP2023527352A5 JP 2023527352 A5 JP2023527352 A5 JP 2023527352A5 JP 2022572524 A JP2022572524 A JP 2022572524A JP 2022572524 A JP2022572524 A JP 2022572524A JP 2023527352 A5 JP2023527352 A5 JP 2023527352A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- cov
- sars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030260P | 2020-05-26 | 2020-05-26 | |
| US63/030,260 | 2020-05-26 | ||
| US202063033198P | 2020-06-01 | 2020-06-01 | |
| US63/033,198 | 2020-06-01 | ||
| US202063093888P | 2020-10-20 | 2020-10-20 | |
| US63/093,888 | 2020-10-20 | ||
| US202063112143P | 2020-11-10 | 2020-11-10 | |
| US63/112,143 | 2020-11-10 | ||
| US202163141956P | 2021-01-26 | 2021-01-26 | |
| US63/141,956 | 2021-01-26 | ||
| US202163142472P | 2021-01-27 | 2021-01-27 | |
| US63/142,472 | 2021-01-27 | ||
| US202163145389P | 2021-02-03 | 2021-02-03 | |
| US63/145,389 | 2021-02-03 | ||
| US202163159437P | 2021-03-10 | 2021-03-10 | |
| US63/159,437 | 2021-03-10 | ||
| PCT/US2021/034187 WO2021242815A1 (en) | 2020-05-26 | 2021-05-26 | Anti-sars-cov-2-spike glycoprotein antibodies and antigen-binding fragments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527352A JP2023527352A (ja) | 2023-06-28 |
| JP2023527352A5 true JP2023527352A5 (https=) | 2024-06-03 |
Family
ID=76859707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572524A Pending JP2023527352A (ja) | 2020-05-26 | 2021-05-26 | 抗ｓａｒｓ－ｃｏｖ－２－スパイク糖タンパク質抗体及び抗原結合断片 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240043504A1 (https=) |
| EP (1) | EP4157868A1 (https=) |
| JP (1) | JP2023527352A (https=) |
| KR (1) | KR20230017815A (https=) |
| CN (1) | CN116096745A (https=) |
| AU (1) | AU2021282179A1 (https=) |
| BR (1) | BR112022024149A2 (https=) |
| CA (1) | CA3179819A1 (https=) |
| IL (1) | IL298194A (https=) |
| MX (1) | MX2022014598A (https=) |
| WO (1) | WO2021242815A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250107297A (ko) | 2020-04-02 | 2025-07-11 | 리제너론 파아마슈티컬스, 인크. | 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편 |
| BR112022024662A2 (pt) | 2020-06-03 | 2023-04-04 | Regeneron Pharma | Métodos para tratamento ou prevenção de infecções por sars-cov-2 e covid-19 com anticorpos de glicoproteína spike anti-sars-cov-2 |
| US12496470B2 (en) | 2021-07-14 | 2025-12-16 | Regeneron Pharmaceuticals, Inc. | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments |
| US20250049006A1 (en) * | 2021-12-20 | 2025-02-13 | C/O Regeneron Pharmaceuticals, Inc. | Non-human animals comprising humanized ace2 and tmprss loci |
| WO2023173577A1 (zh) * | 2022-03-15 | 2023-09-21 | 慧壹科技(上海)有限公司 | 冠状病毒抗体及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
| US4952496A (en) | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US5693489A (en) | 1984-03-30 | 1997-12-02 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| EP2314620B1 (en) * | 2004-05-27 | 2013-06-05 | Crucell Holland B.V. | Method of identifying binding molecules capable of neutralizing rabies virus |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| WO2008020079A1 (en) | 2006-08-18 | 2008-02-21 | Ablynx N.V. | Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
| US7737725B1 (en) | 2008-04-04 | 2010-06-15 | Xilinx, Inc. | Device control register for a processor block |
| EP2285833B1 (en) | 2008-05-16 | 2014-12-17 | Ablynx N.V. | AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME |
| US8409838B2 (en) | 2009-06-02 | 2013-04-02 | Regeneron Pharmaceuticals, Inc. | Fucosylation-deficient cells |
| US20150203591A1 (en) | 2012-08-02 | 2015-07-23 | Regeneron Pharmaceuticals, Inc. | Mutivalent antigen-binding proteins |
| JO3701B1 (ar) | 2014-05-23 | 2021-01-31 | Regeneron Pharma | مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي |
| CN111936517B (zh) | 2018-01-26 | 2025-04-18 | 瑞泽恩制药公司 | 抗tmprss2抗体和抗原结合片段 |
| KR20250107297A (ko) | 2020-04-02 | 2025-07-11 | 리제너론 파아마슈티컬스, 인크. | 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편 |
-
2021
- 2021-05-26 MX MX2022014598A patent/MX2022014598A/es unknown
- 2021-05-26 BR BR112022024149A patent/BR112022024149A2/pt unknown
- 2021-05-26 CN CN202180037834.8A patent/CN116096745A/zh active Pending
- 2021-05-26 JP JP2022572524A patent/JP2023527352A/ja active Pending
- 2021-05-26 IL IL298194A patent/IL298194A/en unknown
- 2021-05-26 WO PCT/US2021/034187 patent/WO2021242815A1/en not_active Ceased
- 2021-05-26 KR KR1020227045049A patent/KR20230017815A/ko active Pending
- 2021-05-26 EP EP21740281.7A patent/EP4157868A1/en active Pending
- 2021-05-26 US US17/927,649 patent/US20240043504A1/en active Pending
- 2021-05-26 CA CA3179819A patent/CA3179819A1/en active Pending
- 2021-05-26 AU AU2021282179A patent/AU2021282179A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023527352A5 (https=) | ||
| JP2017113019A5 (https=) | ||
| Handel et al. | Nuclear factor–kB in rheumatoid synovium. Localization of P50 and P65 | |
| ES2660112T3 (es) | Composiciones para el tratamiento de artritis reumatoide y métodos de uso de las mismas | |
| JP2012504602A5 (https=) | ||
| JP2015508063A5 (https=) | ||
| RU2013141223A (ru) | МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА, КОТОРЫЕ СВЯЗЫВАЮТСЯ С hGM-CSF, И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ МЕДИЦИНСКОГО НАЗНАЧЕНИЯ | |
| JP2013541335A5 (https=) | ||
| JP2009537143A5 (https=) | ||
| JP2018193386A5 (https=) | ||
| JP2011505867A5 (https=) | ||
| JP2011524161A5 (https=) | ||
| JP2010521147A5 (https=) | ||
| EP3949978A1 (en) | Diagnosis and treatment for chronic inflammation and virus infection | |
| JP2018520334A5 (https=) | ||
| JP2019519475A (ja) | ヒト化抗ｃｌｅｖｅｒ−１抗体およびその使用 | |
| CN108473582A (zh) | 用于治疗纤维化和/或纤维化病症的抗－αV整合素抗体 | |
| AU2014268316A1 (en) | Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma | |
| Jiang et al. | Anti-CCL21 antibody attenuates infarct size and improves cardiac remodeling after myocardial infarction | |
| RU2017136863A (ru) | Способы лечения рака легкого | |
| JP2009524428A5 (https=) | ||
| WO2023030315A1 (zh) | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 | |
| WO2022205021A1 (zh) | 一种抗angptl3抗体或其抗原结合片段及其制备方法和用途 | |
| US20200407434A1 (en) | Bispecific antibodies to mospd2 and t cell- or nk cell-specific molecules | |
| CN117230018B (zh) | 抗Cyclophilin A的单克隆抗体及其在治疗病毒性肺炎中的应用 |